Bender Robert & Associates Summit Therapeutics Inc. Put Options Transaction History
Bender Robert & Associates
- $455 Million
- Q2 2024
Put Options
1 transactions
Others Institutions Holding SMMT
# of Institutions
139Shares Held
64.5MCall Options Held
1.06MPut Options Held
1.02M-
Baker Bros. Advisors LP New York, NY23.2MShares$443 Million2.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.82MShares$168 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$151 Million0.0% of portfolio
-
State Street Corp Boston, MA4.12MShares$78.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.96MShares$56.6 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.84B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...